Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/505 (2006.01) A61K 31/522 (2006.01) A61P 3/00 (2006.01) A61P 15/00 (2006.01) A61P 25/00 (2006.01) C07D 231/00 (2006.01) C07D 239/00 (2006.01)

Patent

CA 2436911

Compounds of general formula (I), or pharmaceutically or veterinarily acceptable salts, solvates, polymorphs or pro-drugs thereof wherein: wherein R1, R2, R3, R4, X and A have the meanings given herein which are useful in the curative and prophylactic treatment of a medical condition for which inhibition of a cyclic guanosine 3',5'-monophosphate phosphodiesterase (e.g. cGMP PDE5) is desired.

L'invention concerne des composés représentés par la formule générale (I), ou des sels, des solvates, des polymorphes ou des promédicaments de ces composés, acceptables sur les plans vétérinaire et pharmaceutique, dans laquelle R?1¿, R?2¿, R?3¿, R?4¿, X et A possèdent les significations mentionnées, et qui sont utiles dans le traitement curatif ou prophylactique de troubles médicaux pour lesquels on recherche une inhibition d'une guanosine 3',5'-monophosphate phosphodiestérase cyclique (par exemple la GMPc PDE5).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1660496

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.